Mark A. Dominick

An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing

Frank D. Sistare, Daniel Morton, Carl L. Alden et al. · Toxicologic Pathology · 2011 · 152 citations · Full text

Chemoprevention Strategy, Pathology, Toxicology Testing +17

Ketamine prevents ischemic neuronal injury

F Marcoux, James E. Goodrich, Mark A. Dominick · Brain Research · 1988 · 99 citations

Neurophysiology, Neuropharmacology, Neuroprotection +6

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action

Mark A. Dominick, Melvin R. White, Thomas P. Sanderson et al. · Toxicologic Pathology · 2006 · 92 citations · Full text

Molecular Pharmacology, Urological Research, Urology +14

Subacute Toxicity of a Novel Inhibitor of Acyl-CoA: Cholesterol Acyltransferase in Beagle Dogs

Mark A. Dominick · Fundamental and Applied Toxicology · 1993 · 65 citations

Oxysterol, Biochemistry, Medicine +9

Morphogenesis of a Zone-Specific Adrenocortical Cytotoxicity in Guinea Pigs Administered PD 132301-2, an Inhibitor of Acyl-CoA: Cholesterol Acyltransferase

Mark A. Dominick, Walter A. Bobrowski, John R. MacDonald et al. · Toxicologic Pathology · 1993 · 54 citations · Full text

Pathology, Zone-specific Adrenocortical Cytotoxicity, Glucocorticoid +17